BioCentury
ARTICLE | Company News

Incyte, Novartis deal

February 27, 2012 8:00 AM UTC

Incyte disclosed in its 4Q11 earnings that it received a $10 million milestone payment from Novartis under a 2009 deal granting the pharma exclusive rights to develop and commercialize INCB18424 outs...